Last updated on November 2019

A Study of Ipatasertib in Combination With Paclitaxel as a Treatment for Participants With PIK3CA/AKT1/PTEN-Altered Locally Advanced or Metastatic Triple-Negative Breast Cancer or Hormone Receptor-Positive HER2-Negative Breast Cancer


Brief description of study

This study will evaluate the efficacy of ipatasertib + paclitaxel versus placebo + paclitaxel in participants with histologically confirmed, locally advanced or metastatic triple-negative breast cancer (TNBC) and in participants with locally advanced or metastatic hormone receptor positive (HR+)/ human epidermal growth factor receptor 2 negative (HER2) breast adenocarcinoma who are not suitable for endocrine therapy.

Clinical Study Identifier: NCT03337724

Find a site near you

Start Over

Memorial Hospital West

Pembroke Pines, FL United States
5.28miles
  Connect »

Memorial Regional Hospital

Hollywood, FL United States
5.69miles
  Connect »